Progyny acquires BenefitBump and Teladoc buys Catapult Health for $65M, as digital health companies engage in dealmaking.
AstraZeneca cuts UK investment after government reduces site expansion support; Viking secures API supply; Jabil acquires ...
AstraZeneca has terminated all development of vemircopan, the oral factor D inhibitor it acquired through the deal for ...
After promoting its oncology officer Chris Boshoff to chief scientific officer last fall, Pfizer has found his successor.
Personify Health, which sells healthcare spending management services to employers, has reached more than half a ...
AstraZeneca on Thursday provided insight on an ongoing China probe into the company concerning alleged illegal drug imports, ...
Bristol Myers Squibb announces $2B in new cost cuts over 3 years, including workforce reductions, following $1.5B cuts in ...
It took one month for Johnson & Johnson to secure its $14 billion acquisition of Intra-Cellular Therapies, according to new securities filings that shed light into the back-and-forth talks behind the ...
Many Americans have flocked to cheaper, compounded versions of GLP-1 weight loss drugs in lieu of brand-name treatments. That ...
Revance Therapeutics accepts Crown Laboratories' $3.65/share acquisition offer over rival bid from Teoxane, ending battle for ...
Eli Lilly reports 45% Q4 revenue jump to $13.53B, missing projections. Company maintains 2025 revenue outlook of $58-61B amid competition with Novo Nordisk in obesity market.
Bristol Myers Squibb cuts 67 jobs in Lawrence Township, NJ, while Kyowa Kirin lays off 52 employees at Princeton facility, per NJ WARN notices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback